Tesamorelin 6mg / Ipamorelin 3mg / CJC 1295 3mg

Tesamorelin 6mg + Ipamorelin 3mg + CJC‑1295 3mg

GHRH Analog + Selective GHS + Long‑Acting GHRH Analog • Lyophilized Peptide Blend • Research Use Only

Description: This research‑grade peptide formulation combines Tesamorelin, Ipamorelin, and CJC‑1295 to create a multi‑pathway growth hormone (GH)–modulating model. The blend is widely studied for its synergistic ability to enhance endogenous GH secretion, support visceral fat metabolism, preserve lean muscle mass, and promote cellular repair.

By activating both GHRH and GHS‑R1a pathways—while also extending GH‑release duration through CJC‑1295’s albumin‑binding properties—this combination is frequently used in research involving body recomposition, metabolic health, sleep quality, and endocrine function.

Specifications

• Peptides:

  • Tesamorelin — 6mg

  • Ipamorelin — 3mg

  • CJC‑1295 — 3mg

• Total Peptide Content: 12mg per vial

• Purity: ≥99.8%

• Form: Lyophilized powder

• Storage:

  • Store at –20°C (–4°F)

  • After reconstitution, refrigerate at 2–8°C (36–46°F); use within 30 days

• Grade: Research Use Only — Not for human consumption, therapeutic, or diagnostic use

Mechanistic Overview

Tesamorelin (6mg) — GHRH Analog

• Potently stimulates pituitary GHRH receptors

• Strong research association with visceral adipose tissue (VAT) reduction

• Supports IGF‑1 production, lipid metabolism, and metabolic regulation

Ipamorelin (3mg) — Selective GHS

• Activates GHS‑R1a to produce clean, controlled GH pulses

• Does not significantly elevate cortisol or prolactin in research models

• Supports deep sleep, recovery, and cellular repair

CJC‑1295 (3mg) — Long‑Acting GHRH Analog

• Binds to albumin, extending half‑life and GH‑release duration

• Provides a steady baseline of GH support throughout the day

• Enhances fat mobilization, muscle maintenance, and IGF‑1 signaling

Synergistic Research Effects

Targeted Visceral Fat Reduction

The combined GHRH + GHS stimulation enhances GH‑mediated lipolysis, particularly in deep abdominal fat depots, a major focus in metabolic and aging research.

Improved Body Composition

The blend supports lean muscle preservation while promoting fat mobilization, making it valuable in recomposition and endocrine‑function studies.

Enhanced Sleep & Recovery

Ipamorelin and CJC‑1295 contribute to improved slow‑wave sleep, which is associated with:

• Faster tissue repair

• Enhanced mitochondrial recovery

• Improved next‑day vitality

Anti‑Aging & Collagen Support

Increased GH and IGF‑1 activity is linked to:

• Collagen and elastin synthesis

• Joint and connective‑tissue support

• Skin elasticity and structural integrity

Research Focus Areas

• Growth hormone secretion and multi‑pathway GH‑axis activation

• Visceral adipose tissue and metabolic‑health models

• Body composition, lipolysis, and anti‑aging research

• Sleep quality, recovery, and cellular‑repair studies

• Endocrine function, IGF‑1 signaling, and metabolic regulation

NOTICE

FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION.